Bridging neuroscience leadership and federal policymakers to advance the clinical translation of neurotechnology.
Brain Mapping Day at the US Congress brings together global neurotechnology leaders and policymakers to shape the future of brain health policy.
Neurological disorders cost the United States over $1.6 trillion annually. Brain Mapping Day exists to connect scientific innovation with the policy frameworks needed to deliver real clinical impact.
Each year, researchers, physicians, technology leaders, and legislators gather in the halls of Congress to accelerate the translation of neuroscience into real-world healthcare solutions.
Engage directly with federal legislators and staff shaping neurotechnology policy.
Hear from the world's leading neuroscientists and clinicians.
Join the international SBMT neurotechnology community.
Brain Mapping Day at the US Congress is where neuroscience innovation meets public policy.
